Financial Architects Inc Sells 625 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Financial Architects Inc lessened its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 5.7% in the second quarter, Holdings Channel.com reports. The institutional investor owned 10,290 shares of the health services provider’s stock after selling 625 shares during the period. Financial Architects Inc’s holdings in Teladoc Health were worth $1,711,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Princeton Global Asset Management LLC bought a new stake in shares of Teladoc Health during the second quarter worth about $30,000. Gables Capital Management Inc. bought a new stake in shares of Teladoc Health during the second quarter worth about $33,000. Marshall Wace North America L.P. bought a new stake in shares of Teladoc Health during the first quarter worth about $35,000. Selective Wealth Management Inc. increased its position in shares of Teladoc Health by 4,200.0% during the second quarter. Selective Wealth Management Inc. now owns 215 shares of the health services provider’s stock worth $36,000 after acquiring an additional 210 shares in the last quarter. Finally, Wagner Wealth Management LLC bought a new stake in shares of Teladoc Health during the first quarter worth about $37,000. 79.43% of the stock is owned by institutional investors and hedge funds.

In other Teladoc Health news, CFO Mala Murthy sold 3,851 shares of Teladoc Health stock in a transaction that occurred on Friday, June 25th. The shares were sold at an average price of $165.48, for a total transaction of $637,263.48. Following the transaction, the chief financial officer now owns 21,208 shares of the company’s stock, valued at $3,509,499.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Arnnon Geshuri sold 4,050 shares of Teladoc Health stock in a transaction that occurred on Thursday, August 26th. The shares were sold at an average price of $143.29, for a total transaction of $580,324.50. Following the sale, the insider now owns 88,908 shares in the company, valued at approximately $12,739,627.32. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 23,321 shares of company stock worth $3,567,368. Insiders own 6.47% of the company’s stock.

Several research analysts recently weighed in on TDOC shares. Argus cut shares of Teladoc Health from a “buy” rating to a “hold” rating in a report on Monday, August 2nd. Robert W. Baird began coverage on shares of Teladoc Health in a research note on Thursday, May 27th. They issued a “neutral” rating and a $162.00 target price on the stock. Barclays lowered their price target on shares of Teladoc Health from $240.00 to $170.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 28th. BTIG Research lowered their price target on shares of Teladoc Health from $300.00 to $260.00 and set a “buy” rating on the stock in a research report on Wednesday, July 28th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Teladoc Health from a “buy” rating to a “hold” rating and lowered their price target for the company from $225.00 to $153.00 in a research report on Wednesday, July 28th. Twelve research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, Teladoc Health presently has an average rating of “Buy” and an average target price of $217.75.

NYSE:TDOC traded up $0.54 on Wednesday, reaching $134.26. 41,861 shares of the stock traded hands, compared to its average volume of 3,030,974. The company has a market capitalization of $21.38 billion, a price-to-earnings ratio of -23.58 and a beta of 0.24. The company has a current ratio of 4.00, a quick ratio of 3.79 and a debt-to-equity ratio of 0.08. Teladoc Health, Inc. has a 12 month low of $129.74 and a 12 month high of $308.00. The company’s fifty day simple moving average is $147.05 and its 200 day simple moving average is $161.63.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Tuesday, July 27th. The health services provider reported ($0.86) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.59) by ($0.27). The company had revenue of $503.14 million for the quarter, compared to analysts’ expectations of $499.85 million. Teladoc Health had a negative net margin of 46.86% and a negative return on equity of 1.29%. The business’s revenue was up 108.7% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.34) EPS. Equities analysts anticipate that Teladoc Health, Inc. will post -3.53 EPS for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.

Recommended Story: What is the S&P 500 Index?

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.